{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:21:14Z","timestamp":1773872474347,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T00:00:00Z","timestamp":1150761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00406-006-0665-3","type":"journal-article","created":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T06:19:50Z","timestamp":1150784390000},"page":"437-441","source":"Crossref","is-referenced-by-count":69,"title":["(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population"],"prefix":"10.1007","volume":"256","author":[{"given":"Isabel","family":"Mart\u00ednez-Gras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Hoenicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Rodr\u00edguez\u2013Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Jim\u00e9nez-Arriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"P\u00e9rez-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Ramos-Atance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,6,20]]},"reference":[{"key":"665_CR1","volume-title":"Computer programs for epidemiologists: Pepi version 4.0.","author":"JH Abramson","year":"2001","unstructured":"Abramson JH, Gahlinger PM (2001) Computer programs for epidemiologists: Pepi version 4.0. Sagebrush Press, Salt Lake City"},{"key":"665_CR2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"ii","author":"S Andreasson","year":"1987","unstructured":"Andreasson S, Allebeck P, Engstr\u00f6m A, Rydberg U (1987) Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet ii: 1483\u20131486","journal-title":"Lancet"},{"key":"665_CR3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0033291700030324","volume":"22","author":"S Arndt","year":"1992","unstructured":"Arndt S, Tyrrell G, Flaum M, Andreasen N (1992) Comorbidity of substance abuse and schizophrenia. The role of pre-morbid adjustment. Psychol Med 22:379\u2013388","journal-title":"Psychol Med"},{"key":"665_CR4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","volume":"325","author":"L Arseneault","year":"2002","unstructured":"Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Brit Med J 325:1212\u20131213","journal-title":"Brit Med J"},{"key":"665_CR5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray R (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117","journal-title":"Br J Psychiatry"},{"key":"665_CR6","first-page":"357","volume":"1","author":"J Blackwell","year":"1987","unstructured":"Blackwell J, Beresfors J (1987) Cannabis self-medication and adverse reactions in psychyatric patients. Soc Pharmacol 1:357\u2013358","journal-title":"Soc Pharmacol"},{"key":"665_CR7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","volume":"57","author":"A Caspi","year":"2005","unstructured":"Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57:1117\u20131127","journal-title":"Biol Psychiatry"},{"key":"665_CR8","first-page":"1037","volume":"40","author":"C Caton","year":"1989","unstructured":"Caton C, Gralnick A, Bender S, Simon R (1989) Young chronic patients and substance abuse. Hosp Community Psychiatry 40:1037\u20131040","journal-title":"Hosp Community Psychiatry"},{"key":"665_CR9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1360-0443.1991.tb01874.x","volume":"86","author":"HR Chaudry","year":"1991","unstructured":"Chaudry HR, Moss HB, Bashir A, Suliman T (1991) Cannabis psychosis following bhang ingestion. Br J Addict 86:1075\u20131081","journal-title":"Br J Addict"},{"key":"665_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"JP Chen","year":"1990","unstructured":"Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990) Delta-9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156\u2013162","journal-title":"Psychopharmacology"},{"key":"665_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.mp.4000247","volume":"2","author":"DE Comings","year":"1997","unstructured":"Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G (1997) Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry 2:161\u2013168","journal-title":"Mol Psychiatry"},{"key":"665_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00005053-199209000-00008","volume":"180","author":"BJ Cuffel","year":"1992","unstructured":"Cuffel BJ (1992) Prevalence estimates of substance abuse in schizophrenia and their correlates. J Nerv Ment Dis 180:589\u2013592","journal-title":"J Nerv Ment Dis"},{"issue":"S50\u2013S51","key":"665_CR13","first-page":"850","volume":"5","author":"E Dawson","year":"1995","unstructured":"Dawson E (1995) Identification of a polymorphic triplet repeat marker for the brain cannabinoid receptor gene: use in linkage and association studies. Psychiatr Genet 5 (S50\u2013S51):850","journal-title":"Psychiatr Genet"},{"key":"665_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R, Scarr E, Coplov D (2001) Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9\u201315","journal-title":"Neuroscience"},{"key":"665_CR15","first-page":"1041","volume":"40","author":"RE Drake","year":"1989","unstructured":"Drake RE, Wallack MA (1989) Substance abuse among the chronic mentally ill. Hosp Community Psychiatry 40:1041\u20131045","journal-title":"Hosp Community Psychiatry"},{"key":"665_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291702006402","volume":"33","author":"DM Fergusson","year":"2003","unstructured":"Fergusson DM, Horwood LJ, Swain-Campbell NR (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med 33:15\u201321","journal-title":"Psychol Med"},{"key":"665_CR17","doi-asserted-by":"crossref","unstructured":"Firsts MB, Spitzer RL, Gibbon M, et al. (1995) Structured Clinical Interview for DSM-IV Axis I Disorders Patient Edition (SCID-IP, Version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute","DOI":"10.1037\/t07827-000"},{"key":"665_CR18","first-page":"275","volume-title":"Marijuana\/cannabinnoids. Neurobiology and neurophysiology","author":"EL Gardner","year":"1992","unstructured":"Gardner EL (1992) Cannabinoid interaction with brain reward systems. The neurobiological basis of cannabinoid abuse. In: Murphy L, Bartke A (eds) Marijuana\/cannabinnoids. Neurobiology and neurophysiology. CRC Press, Boca Raton, FL, pp 275\u2013335"},{"key":"665_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.1972.01750260016003","volume":"27","author":"JA Halikas","year":"1972","unstructured":"Halikas JA, Goodwin DW, Guze SB (1972) Marihuana use and psychiatric illness. Arch Gen Psychiatry 27:162\u2013165","journal-title":"Arch Gen Psychiatry"},{"key":"665_CR20","first-page":"880","volume":"3","author":"MR Hoehe","year":"1991","unstructured":"Hoehe MR, Caenazzo L, Mart\u00ednez MM, Hsieh WT, Modi WS, Gershon ES, Bonner TI (1991) Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14\u2013q15. New Biol 3:880\u2013885","journal-title":"New Biol"},{"key":"665_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.mp.4000246","volume":"2","author":"JP Johnson","year":"1997","unstructured":"Johnson JP, Muhleman D, Mc Murray J, Gade R, Verde R, Ask M, Kelley J, Comings DE (1997) Association between the cannaboind receptor gene (CNR1) and the P300 event-related potential. Mol Psychiatry 2:169\u2013171","journal-title":"Mol Psychiatry"},{"key":"665_CR22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A Johns","year":"2001","unstructured":"Johns A (2001) Psychiatric effects of cannabis. Br J Psychiatry 178:116\u2013122","journal-title":"Br J Psychiatry"},{"key":"665_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","volume":"15","author":"C Ledent","year":"1999","unstructured":"Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 15:401","journal-title":"Science"},{"issue":"6","key":"665_CR24","first-page":"556","volume":"45","author":"AF Lehman","year":"1994","unstructured":"Lehman AF, Myers CP, Dixon LB, Johnson JL (1994) Defining subgroups of dual diagnosis patitns for service planning. Hosp Community Psychiatry 45(6):556\u2013561","journal-title":"Hosp Community Psychiatry"},{"issue":"8","key":"665_CR25","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999) Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10(8):1665\u20131669","journal-title":"Neuroreport"},{"key":"665_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.mp.4000670","volume":"5","author":"T Li","year":"2000","unstructured":"Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM, Sham PC, Collier DA (2000) No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 5:128\u2013130","journal-title":"Mol Psychiatry"},{"key":"665_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DJ Linzsen","year":"1994","unstructured":"Linzsen DJ, Dingemans PM, Leniorm ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273\u2013279","journal-title":"Arch Gen Psychiatry"},{"key":"665_CR28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1192\/bjp.161.5.648","volume":"161","author":"DC Mathers","year":"1992","unstructured":"Mathers DC, Ghodse AH (1992) Cannabis and psychotic illness. Br J Psychiatry 161:648\u2013653","journal-title":"Br J Psychiatry"},{"key":"665_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0920-9964(94)90097-3","volume":"13","author":"PK McGuire","year":"1994","unstructured":"McGuire PK, Jones P, Harvey L (1994) Cannabis and acute psychosis. Schizophr Res 13:161\u2013167","journal-title":"Schizophr Res"},{"issue":"6","key":"665_CR30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4603(98)00073-2","volume":"23","author":"KT Mueser","year":"1998","unstructured":"Mueser KT, Drake RE, Wallach MA (1998) Dual diagnosis: a review of etiological theories. Addict Behav 23(6):717\u2013734","journal-title":"Addict Behav"},{"key":"665_CR31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.1989.tb00576.x","volume":"84","author":"JC Negrete","year":"1989","unstructured":"Negrete JC (1989) Cannabis and schizophrenia. Br J Addict 84:349\u2013351","journal-title":"Br J Addict"},{"key":"665_CR32","first-page":"1025","volume":"40","author":"F Osher","year":"1989","unstructured":"Osher F, Kofoed L (1989) Treatment of patients with psychiatric and psychoactive substance abuse disorders. Hosp Community Psychiatry 40:1025\u20131030","journal-title":"Hosp Community Psychiatry"},{"key":"665_CR33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.mp.4001278","volume":"8","author":"G Ponce","year":"2003","unstructured":"Ponce G, Hoenicka J, Rubio G, Ampuero I, Jim\u00e9nez-Arriero MA, Rodr\u00edguez-Jim\u00e9nez R, Palomo T, Ramos JA (2003) Association between cannabinoid receptor gene (CNR1) and childhood attention deficit\/hyperactivity disorder in Spanish male alcoholic patients. Mol Psychiatry 8:466\u2013467","journal-title":"Mol Psychiatry"},{"key":"665_CR34","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.23-06-02453.2003","volume":"23","author":"I Racz","year":"2003","unstructured":"Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A (2003) A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 23:2453","journal-title":"J Neurosci"},{"key":"665_CR35","unstructured":"Rubio G (1999) Consumo de cannabis en diferentes grupos de poblaci\u00f3n. In: Cabrera J (ed) Cannabis Hasta dondel Jornadas de expertos en cannabis en la Comunidad de Madrid, Comunidad de Madrid Agenica Antidrogal, pp 167\u2013184"},{"key":"665_CR36","first-page":"124","volume":"29","author":"G Rubio","year":"2001","unstructured":"Rubio G, Casas M (2001) Revisi\u00f3n del tratamiento de la esquizofrenia en individuos con abuso de drogas. Act Esp Psiquiat 29:124\u2013130","journal-title":"Act Esp Psiquiat"},{"key":"665_CR37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00005053-198711000-00001","volume":"175","author":"FR Schneier","year":"1987","unstructured":"Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Ment Dis 175:641\u2013652","journal-title":"J Nerv Ment Dis"},{"key":"665_CR38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1176\/ajp.128.11.1381","volume":"128","author":"C Shearn","year":"1972","unstructured":"Shearn C, Fitzgibbons D (1972) Patterns of dugs use in a population of youthful psychiatric patients. Am J Psychiatry 128:65\u201371","journal-title":"Am J Psychiatry"},{"key":"665_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(01)00164-8","volume":"65","author":"LG Schmidt","year":"2002","unstructured":"Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B, Rommelspacher H, Hoehe MR (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65:221\u2013224","journal-title":"Drug Alcohol Depend"},{"key":"665_CR40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/schbul\/15.3.465","volume":"15","author":"MA Test","year":"1989","unstructured":"Test MA, Wallisch DJ, Allness D, Ripp K (1989) Substance use in young adults with schizophrenic disorders. Schizophrenia Bull 15:465\u2013476","journal-title":"Schizophrenia Bull"},{"key":"665_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00041444-200010030-00008","volume":"10","author":"SJ Tsai","year":"2000","unstructured":"Tsai SJ, Wang YC, Hong CJ (2000) Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatric Genet 10:149\u2013151","journal-title":"Psychiatric Genet"},{"key":"665_CR42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/schbul\/16.1.87","volume":"16","author":"VM Turner","year":"1990","unstructured":"Turner VM, Tsuang MT (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophrenia Bull 16:87\u201395","journal-title":"Schizophrenia Bull"},{"key":"665_CR43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","volume":"7","author":"H Ujike","year":"2002","unstructured":"Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda S (2002) CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 7:515\u2013518","journal-title":"Mol Psychiatry"},{"key":"665_CR44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/aje\/kwf043","volume":"156","author":"J Os Van","year":"2002","unstructured":"Van Os J, Bak M, Hanssen M, Bijl RV, De Graaf R, Verdoux H (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156:19\u201327","journal-title":"Am J Epidemiol"},{"key":"665_CR45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ajmg.10647","volume":"114","author":"M Weiser","year":"2002","unstructured":"Weiser M, Knobler HY, Noy S, Kaplan Z (2002) Clinical characteristics of adolescents later hospitalized for schizophrenia. Am J Med Genet 114:949\u2013955","journal-title":"Am J Med Genet"},{"key":"665_CR46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","volume":"325","author":"S Zammit","year":"2002","unstructured":"Zammit S, Allebeck P, Andreasson S, Lundberg l, Lewis G (2002) Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Brit Med J 325:1199\u20131201","journal-title":"Brit Med J"},{"key":"665_CR47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.mp.4001560","volume":"9","author":"PW Zhang","year":"2004","unstructured":"Zhang PW, Isighuro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR (2004) Human cannabinoid receptor 1:5\u2019 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysusbstance abuse. Mol Psychiatry 9:916\u2013931","journal-title":"Mol Psychiatry"},{"key":"665_CR48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","volume":"28","author":"K Zavitsanou","year":"2004","unstructured":"Zavitsanou K, Garrick T, Huang XF (2004) Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulated cortex in schizophrenia. Pro. Neuropsychopharmacol Biol Psychiatry 28:355\u2013360","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"665_CR49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jphs.FMJ04003X4","volume":"96","author":"H Ujike","year":"2004","unstructured":"Ujike H, Morita Y (2004) New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. J Pharmacol Sci 96(4):376\u2013381","journal-title":"J Pharmacol Sci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-006-0665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-006-0665-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-006-0665-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:20:03Z","timestamp":1559067603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-006-0665-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,20]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s00406-006-0665-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,20]]}}}